IMMUNEONCO BIOPHARMACEUTICALS (SHAN
(HKEX: 1541)
ImmuneOnco Biopharmaceuticals (Shanghai) Co., Ltd. operates as an early-stage biopharmaceutical company which develops and commercializes novel cancer immunotherapeutic products. It focus on the adaptive immune system and are often confronted with limited clinical benefits due to low response rates and inevitable drug resistance and/or relapse in many cancer indications. The company was founded by Dr. Tian Wenzhi in June 2015 and is headquartered in Zhangjiang Science City, China.
14.500 -
+0.020
(+0.14%)
Range
14.500 - 14.880
(2.62%)
Open
14.600
Previous Close
14.480
Bid Price
14.500
Bid Volume
('000)
7.4
Ask Price
14.700
Ask Volume
('000)
1
Volume
('000)
202.2
Value
2,993,856
Remark
-
View All Events
Loading Chart...
Please login to view stock data and analysis